Durham, NC (PRWEB) July 22, 2014
Clinverse, Inc., provider of the first end-to-end technology solution for automating the financial lifecycle of global clinical trials, announced the addition of Shaun Williams as Vice President, Operations and the promotion of Heather Schultz to the newly created role of Senior Vice President, Product Solutions.
As Vice President, Operations, Shaun will oversee all operational aspects of the company, including implementation services for new clients and ongoing support for existing clients. He brings more than 20 years of experience directing a broad spectrum of operational activities in FDA-regulated industries, including medical device, pharmaceutical, and biotechnology. Prior to joining Clinverse, Shaun most recently provided consulting services to life sciences companies, specializing in the design and implementation of quality systems for FDA-regulated companies. Shaun also served as the Vice President of Operations at Health Decisions, Inc., a North Carolina-based clinical research organization (CRO). He began his career with Baxter Healthcare Corporation after graduating from West Point with a degree in Mechanical Engineering and serving for 6 years in the United States Army.
In her new position as Senior Vice President, Product Solutions, Heather will work closely with Clinverse’s current and prospective clients to provide her significant expertise in the development and optimization of the financial lifecycle of clinical trials. Since joining Clinverse in 2011, Heather served as the Vice President, Operations where she developed process standards and a scalable services organization and was responsible for the implementation of all of ClinPay’s install base. Prior to joining Clinverse, Heather held various roles of graduating responsibility in global project management, performance optimization, and regulatory affairs at pharma/biotech companies and a large global CRO. Heather knows firsthand the issues that sponsors and CROs face when managing investigator payments manually and how implementing an automated payment technology solution like ClinPay solves these issues, while providing efficiency, transparency, and cost-savings.
Continuing with last year’s hiring trajectory, Clinverse increased its overall headcount by almost 10% in the first half of 2014, including the creation of 7 new positions. The increase in headcount is due to the significant growth Clinverse experienced in 2013 and to date in 2014, including signing several top 10 pharmaceutical and biotech sponsors and CROs.
“We are excited to welcome Shaun to our management team. We look forward to leveraging his experience while continuing to benefit from Heather’s expertise as we remain dedicated to expanding our global client base,” said Denis Connaghan, CEO of Clinverse. “The creation of the SVP, Product Solutions role will allow us to more quickly identify, establish, and support best practices and the integration of new ideas to meet the clinical trial financial management needs of our clients. Our continued growth is further validation that the market is seeing our automated investigator payment solution as more of a necessity for optimizing the clinical trial process.”
About Clinverse, Inc.
Clinverse, Inc. architected the industry’s first end-to-end technology solution that automates the financial lifecycle of global clinical trials. Powered by our secure technology platform, our solution standardizes clinical trial finance and manages millions of financial transactions across the globe, including clinical site payments. Used by leading BioPharma companies, our clients benefit from reduced workload, time, and costs gained through automation and unprecedented transparency and workflow. For more information, please visit http://www.clinverse.com.